Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 286

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Bleomycin, an Antitumor Antibiotic: Clinical Experience in 274 Patients

YAGODA, ALAN, MUKHERJI, BIJAY, YOUNG, CHARLES, ETCUBANAS, ERLINDA, LAMONTE, CHARLES, SMITH, JULIUS R., TAN, CHARLOTTE T. C., KRAKOFF, IRWIN H.·1972·Annals of Internal Medicine

Abstract

Bleomycin, a mixture of antibiotic polypeptides, was evaluated for therapeutic activity and clinical toxicology in 274 patients with far-advanced, nonresectable neoplastic disease. Therapeutic effect was most marked in advanced Hodgkin's disease, in which 50% of patients had significant objective and subjective improvement, in some cases for periods now approaching 2 years. Scattered responses of brief duration were seen in other neoplastic diseases. The clinical toxicity of bleomycin appears to be unique among antitumor agents; it produces no important effects on the blood-forming organs, gastrointestinal tract, liver, kidneys, or central nervous system. Pulmonary functional impairment, however, is common; irreversible pulmonary fibrosis, although rare, is a serious, sometimes lethal, manifestation of bleomycin toxicity that may limit its use in early neoplastic disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.7326/0003-4819-77-6-861

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Cited by

See all 286

Metadata

Authors
YAGODA, A., MUKHERJI, B., YOUNG, C., ETCUBANAS, E., LAMONTE, C., SMITH, J. R., TAN, C. T. C., & KRAKOFF, I. H.
Venue
Annals of Internal Medicine
Published
1972-12-01
Volume
77
Issue
6
Pages
861-870
ISSN
  • 0003-4819 (ISSN-L)
  • 1539-3704
OpenAlex
W2012740157
Cited by
286
References
9
FWCI
3.91
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Bleomycin, an Antitumor Antibiotic: Clinical Experience in 274 Patients. https://app.cochat.ai/papers/10.7326/0003-4819-77-6-861
The paper
YAGODA, A., MUKHERJI, B., YOUNG, C., ETCUBANAS, E., LAMONTE, C., SMITH, J. R., TAN, C. T. C., & KRAKOFF, I. H. (1972). Bleomycin, an Antitumor Antibiotic: Clinical Experience in 274 Patients. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-77-6-861

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.